A global biopharmaceutical company focuses on discovering, developing, and commercializing novel antibody therapeutics, primarily targeting oncology and immunology. It utilizes proprietary antibody technology platforms to create fully human monoclonal antibodies and innovative immune cell engagers for enhanced tumor-killing effects.